Significant research is being conducted to improve the understanding and treatment of APL. Studies are focusing on the molecular mechanisms underlying the disease, the development of new targeted therapies, and the identification of biomarkers for early detection and monitoring. Clinical trials are also exploring the efficacy of combining existing treatments with novel agents to further improve outcomes.
